Abstract:A series of novel 3,9-disubstituted acridines were synthesized and their biological potential was investigated. The synthetic plan consists of eight reaction steps, which produce the final products, derivatives 17a-17j, in a moderate yield. The principles of cheminformatics and computational chemistry were applied in order to study the relationship between the physicochemical properties of the 3,9-disubstituted acridines and their biological activity at a cellular and molecular level. The selected 3,9-disubstituted acridine derivatives were studied in the presence of DNA using spectroscopic (UV-Vis, circular dichroism, and thermal denaturation) and electrophoretic (nuclease activity, relaxation and unwinding assays for topoisomerase I and decatenation assay for topoisomerase IIα) methods. Binding constants (2.81-9.03 × 104 M-1) were calculated for the derivatives from the results of the absorption titration spectra. The derivatives were found to have caused the inhibition of both topoisomerase I and topoisomerase IIα. Molecular docking simulations suggested a different way in which the acridines 17a-17j can interact with topoisomerase I versus topoisomerase IIα. A strong correlation between the lipophilicity of the derivatives and their ability to stabilize the intercalation complex was identified for all of the studied agents. Acridines 17a-17j were also subjected to in vitro screening conducted by the Developmental Therapeutic Program of the National Cancer Institute (NCI) against a panel of 60 cancer cell lines. The strongest biological activity was displayed by aniline acridine 17a (MCF7-GI50 18.6 nM) and N,N-dimethylaniline acridine 17b (SR-GI50 38.0 nM). The relationship between the cytostatic activity of the most active substances (derivatives 17a, 17b, and 17e-17h) and their values of KB, LogP, ΔS°, and δ was also investigated. Due to the fact that a significant correlation was only found in the case of charge density, δ, it is possible to assume that the cytostatic effect might be dependent upon the structural specificity of the acridine derivatives.

Novel Synthetic Azaacridine Analogues As Topoisomerase 1 Inhibitors

ChemInform Abstract: Novel Synthetic Azaacridine Analogues As Topoisomerase 1 Inhibitors.

Synthesis and Biological Research of Novel Azaacridine Derivatives As Potent DNA-binding Ligands and Topoisomerase II Inhibitors

Novel Synthetic 9-Benzyloxyacridine Analogue As Both Tyrosine Kinase and Topoisomerase I Inhibitor

Synthesis and Antiproliferative Activity of 9-Benzylamino-6-chloro-2-methoxy-acridine Derivatives As Potent DNA-binding Ligands and Topoisomerase II Inhibitors.

Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.

Novel Synthetic 2-Amino-10-(3,5-dimethoxy)benzyl-9(10h)-acridinone Derivatives As Potent DNA-binding Antiproliferative Agents.

Novel 3,9-Disubstituted Acridines with Strong Inhibition Activity against Topoisomerase I: Synthesis, Biological Evaluation and Molecular Docking Study

Synthesis and Anticancer Research ofN-(2-aminophenyl)benzamide Acridine Derivatives as Dual Topoisomerase I and Isoform-Selective HDAC Inhibitors

A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell.

Design, synthesis and biological evaluation of novel mansonone E derivatives prepared via CuAAC click chemistry as topoisomerase II inhibitors.

A Novel Dna Topoisomerase I Inhibitor with Different Mechanism from Camptothecin Induces G2/M Phase Cell Cycle Arrest to K562 Cells

Design and synthesis of Aza-boeravinone derivatives as potential novel topoisomerase I inhibitors

Synthesis Of Novel Benzoxanthone Analogues As Non-Camptothecin Topoisomerase I Inhibitors

Novel 4-(4-substituted Amidobenzyl)furan-2(5H)-one Derivatives As Topoisomerase I Inhibitors.

Design, Synthesis and Cytotoxicity of Thiazole-Based Stilbene Analogs as Novel DNA Topoisomerase IB Inhibitors

Synthesis, Cytotoxicity and Structure-Activity Relationship of Indolizinoquinolinedione Derivatives As DNA Topoisomerase IB Catalytic Inhibitors

Structure-activity Relationship of Novel Acridone Derivatives As Antiproliferative Agents.

Synthesis and Biological Evaluation of 6-Substituted Indolizinoquinolinediones As Catalytic DNA Topoisomerase I Inhibitors.

Novel Synthetic 9-Benzyloxyacridine Analogue As Both Tyrosine Kinase and Topoisomeras I Inhibitor.

Novel Synthetic Isoquinolino[5,4-Ab]phenazines: Inhibition Toward Topoisomerase I, Antitumor and DNA Photo-Cleaving Activities.